Amman Pharmaceutical Industries

Amman Pharmaceutical Industries specializes in ophthalmic solutions, specifically preservative-free eye drops. These are formulated to lubricate the eyes and provide temporary relief from dry eye symptoms, irritation, discomfort, or excessive tearing caused by environmental factors or prolonged digital screen use.

Amman Pharmaceutical Industries is based in Jordan (JO), as indicated by its country designation.

The company’s eye drops, such as the i ViVA Plus Eye Drops, fall under EU Medical Device Regulation (MDR) Class IIb. This classification is determined based on the intended purpose, risk assessment, and potential harm to patients if misused or malfunctioning, requiring stricter regulatory oversight than lower-risk devices.

Yes, the company’s devices are registered in EUDAMED, the European Union’s medical device registry. This database tracks devices placed on the market within the European Economic Area (EEA) to ensure transparency and compliance with regulatory requirements.

The Class IIb classification for Amman Pharmaceutical Industries’ eye drops reflects their role in treating a condition (dry eye) that, if left unmanaged, could lead to discomfort or potential eye surface damage. This classification triggers additional scrutiny during design, manufacturing, and post-market surveillance to ensure safety and efficacy, aligning with EU MDR requirements for medium-risk devices.